Luwad, Nora Ina S.

HRN: 15-83-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2025
AZITHROMYCIN 500MG TABLET (TAB)
10/17/2025
10/22/2025
PO
500mg
OD
CAP MR
Waiting Final Action 
10/17/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/17/2025
10/24/2025
IV
4.5gms
Q6
CAP MR
10/18/2025
CEFUROXIME 1.5GM (VIAL)
10/18/2025
10/18/2025
IV
1.5g
Now Dose
CAP MR
Waiting Final Action 
10/18/2025
CEFUROXIME 750MG (VIAL)
10/18/2025
10/25/2025
IV
750mg
Q8
CAPMR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: